A recent examination of survey data from Gallup shows that Republican backing for cannabis legalization has reached an unprecedented peak on a nationwide scale. However, a deepening partisan schism has emerged over the last couple of decades, with Democrats having swiftly and more openly embraced this cause. Most Democrats and Independents leaning toward the Democratic Party (amounting to 83%) and also Republicans and Independents with an inclination toward the GOP (accounting for 55%) are in favor of dismantling the ban on cannabis.
These insights, extracted from Gallup’s 2022 survey data, illustrate a disparity of 28% in opinion on the matter of cannabis reform between these political factions. The divergence is now broader compared to the scenario two decades ago when backing from both sides was less than 50%.
According to the most recent research, Democrats have demonstrated a more positive attitude toward marijuana legalization than Republicans since 2003. The data continues by revealing that between 2013 and 2022, there was a synchronized increase in the number of each political party’s supporters of legalizing marijuana. However, Democratic group growth has exceeded Republican faction growth. This has caused the political gap on this matter to be slightly more apparent in the most recent measuring year compared to two decades ago.
Marijuana legalization is one of nine issues out of the 24 analyzed by Gallup, where both political parties are typically in agreement with the majority opposition or support at different levels. The closest comparison to the marijuana debate is same-sex marriage, with a 28%-point political margin; it is supported by 57% of Republicans and 85% of Democrats.
“Political polarization continues to be a critically important feature of the American political landscape,” the report states. “On all 24 of the subjects examined in this analysis, there are now major — and in some cases, enormous — partisan disparities in opinion. This affirms the essential tenet of any American political analysis, which holds that people’s political identities are strongly connected with their opinions on policy and social problems giving rise to significant variations in those opinions among political segments.”
A number of other analyses issued this year support the idea that a majority of Americans, regardless of party affiliation, are willing to reform federal cannabis laws. However, while the majority of states have approved some kind of medical marijuana and 23 states have already passed legislation legalizing cannabis for recreational use, efforts to adopt federal changes have lagged well behind public sentiment.
This lag between public sentiment and actions in Congress suggest that it may take a while for federal marijuana policy to be overhauled. Despite this gloomy possibility, companies such as IGC Pharma Inc. (NYSE American: IGC) are on course to thrive as sellers of federally approved cannabis-based treatments if their R&D programs yield successful outcomes.
NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.
